NCT00690807View on ClinicalTrials.gov

A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Atopic Dermatitis
Interventions
DRUG

PH-10

PH-10 will be applied daily for 28 days to skin areas affected by atopic dermatitis.

Trial Locations (2)

10029

Mount Sinai School of Medicine, New York

33144

International Dermatology Research, Miami

Sponsors
All Listed Sponsors
lead

Provectus Pharmaceuticals

INDUSTRY